Why Certain Vaccines Have Been Delayed Or Not Developed At All
- 1 May 2005
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 24 (3) , 631-634
- https://doi.org/10.1377/hlthaff.24.3.631
Abstract
Vaccine development is a long process, with the time from early research to licensure steadily increasing. At one time the process took about ten years; now it takes closer to fifteen to twenty years. The process begins with investigators in universities or biotech firms who have an idea. However, to take things further, there must be a vaccine manufacturer, a regulatory authority ready to give permission for the use of the vaccine, and public health authorities that will recommend and foster vaccination.Keywords
This publication has 7 references indexed in Scilit:
- Why Are Pharmaceutical Companies Gradually Abandoning Vaccines?Health Affairs, 2005
- Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortantsVirus Research, 2004
- Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescentsThe Pediatric Infectious Disease Journal, 2004
- The introduction of new vaccines into developing countriesVaccine, 2004
- Vaccines, Vaccination, and VaccinologyThe Journal of Infectious Diseases, 2003
- The First Rotavirus Vaccine and Intussusception: Epidemiological Studies and Policy DecisionsThe Journal of Infectious Diseases, 2003
- The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in ChildrenNew England Journal of Medicine, 1998